Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients.

Tanaka Y, Tashiro H, Onoe T, Ide K, Ishiyama K, Ohdan H.

Transplant Proc. 2012 Mar;44(2):555-9. doi: 10.1016/j.transproceed.2012.01.038.

PMID:
22410068
2.
3.

Evaluation of lymphoproliferative responses by carboxy fluorescein succinimidyl ester assay in heart recipients with infections.

Valor L, Sarmiento E, Navarro J, Gallego A, Fernandez-Yañez J, Fernandez-Cruz E, Carbone J.

Transplant Proc. 2012 Nov;44(9):2649-52. doi: 10.1016/j.transproceed.2012.09.054.

PMID:
23146483
4.
5.

Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.

Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.

Transpl Immunol. 2008 Nov;20(1-2):3-5. doi: 10.1016/j.trim.2008.08.008. Epub 2008 Sep 4.

PMID:
18773959
6.

The risk factors to predict acute rejection in liver transplantation.

Wang YC, Wu TJ, Wu TH, Lee CF, Chou HS, Chan KM, Lee WC.

Transplant Proc. 2012 Mar;44(2):526-8. doi: 10.1016/j.transproceed.2012.01.041.

PMID:
22410062
7.

An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.

Akl A, Jones ND, Rogers N, Bakr MA, Mostafa A, El Shehawy el M, Ghoneim MA, Wood KJ.

Transpl Int. 2008 Jan;21(1):65-73. Epub 2007 Sep 20.

8.

The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.

Meadows HB, Taber DJ, Pilch NA, Tischer SM, Baliga PK, Chavin KD.

Transplant Proc. 2012 Jun;44(5):1323-8. doi: 10.1016/j.transproceed.2012.01.110.

PMID:
22664009
9.

Intracellular interferon-γ staining analysis of donor-specific T-cell responses in liver transplant recipients.

Okanami Y, Tsujimura K, Mizuno S, Tabata M, Isaji S, Akatsuka Y, Kuzushima K, Takahashi T, Uemoto S.

Transplant Proc. 2012 Mar;44(2):548-54. doi: 10.1016/j.transproceed.2011.11.007.

PMID:
22410067
10.

Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.

Sakai H, Ishiyama K, Tanaka Y, Ide K, Ohira M, Tahara H, Abe T, Hirata F, Morimoto H, Hashimoto S, Tanimine N, Saeki Y, Shimizu S, Yano T, Kobayashi T, Tashiro H, Ohdan H.

Transplant Proc. 2014 Apr;46(3):785-9. doi: 10.1016/j.transproceed.2013.11.123.

PMID:
24767349
11.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, Ciancio G, Burke G, Roth D, Temple D, Fuller L, Esquenazi V, Eskind L, Kenyon NS, Ricordi C, Tzakis A, Miller J.

Transplantation. 1998 Apr 15;65(7):956-65.

PMID:
9565101
12.
13.

"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.

De Paolis P, Favarò A, Piola A, Martini F, Cristiana G, Agrati C, Iappelli M, Di Giulio S.

Transplant Proc. 2011 May;43(4):1013-6. doi: 10.1016/j.transproceed.2011.02.043.

PMID:
21620039
14.

Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.

Israeli M, Ben-Gal T, Yaari V, Valdman A, Matz I, Medalion B, Battler A, Sredni B, Kristt D, Klein T.

Transplantation. 2010 Apr 27;89(8):968-76. doi: 10.1097/TP.0b013e3181cbabe6.

PMID:
20075792
15.

Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.

Ravaioli M, Neri F, Lazzarotto T, Bertuzzo VR, Di Gioia P, Stacchini G, Morelli MC, Ercolani G, Cescon M, Chiereghin A, Del Gaudio M, Cucchetti A, Pinna AD.

Transplantation. 2015 Aug;99(8):1625-32. doi: 10.1097/TP.0000000000000650.

PMID:
25757214
16.

Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.

Liang H, Liao C, Qi Z, Sha C, Xie B, Chen J, Xia J, Wang Y, Yao Q, Zhao Y.

Transpl Immunol. 2010 Feb;22(3-4):128-36. doi: 10.1016/j.trim.2009.09.003. Epub 2009 Sep 13.

PMID:
19755159
17.

Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?

Joo DJ, Ju MK, Huh KH, Kim MS, Choi GH, Choi JS, Jeon KO, Kim SI.

Transplant Proc. 2012 Mar;44(2):418-20. doi: 10.1016/j.transproceed.2012.01.071.

PMID:
22410032
18.

Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients.

Martínez-Flores JA, Serrano M, Morales P, Paz-Artal E, Morales JM, Serrano A.

J Immunol Methods. 2014 Jan 31;403(1-2):62-5. doi: 10.1016/j.jim.2013.11.019. Epub 2013 Nov 27.

PMID:
24291342
19.

Role of HLA compatibility in pediatric living-related liver transplantation.

Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, Kaihara S, Egawa H, Tanaka K.

Transplantation. 2002 Oct 27;74(8):1175-80.

PMID:
12438966
20.

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ.

Liver Transpl. 2006 Feb;12(2):277-84.

Supplemental Content

Support Center